Advertisement

Topics

Midatech Pharma submits application for first human clinical trial study of rare cancers treatment

03:50 EDT 4 Sep 2017 | Proactive Investors

The AIM-listed company said it expects to enter the clinical stage in the fourth quarter of 2017, pending regulatory approval to conduct the clinical trial, which is expected shortly

Original Article: Midatech Pharma submits application for first human clinical trial study of rare cancers treatment

NEXT ARTICLE

More From BioPortfolio on "Midatech Pharma submits application for first human clinical trial study of rare cancers treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...